Q3 2025 Holdings
Filed 2025-11-14 | 36 holdings | $3.5B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Nuvalent Inc(NUVL) | COM | 670703107 | $455.7M | 5,269,433 | 13.0% |
| Merus N V | COM | N5749R100 | $411.8M | 4,373,770 | 11.7% |
| Arcellx Inc(ACLX) | COMMON STOCK | 03940C100 | $381.7M | 4,649,016 | 10.9% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $290.6M | 6,223,291 | 8.3% |
| Tarsus Pharmaceuticals Inc(TARS) | COM | 87650L103 | $158.4M | 2,665,698 | 4.5% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $136.3M | 3,784,755 | 3.9% |
| Abivax SA(ABVX) | SPONSORED ADS | 00370M103 | $132.8M | 1,564,196 | 3.8% |
| Genmab A/S(GMAB) | SPONSORED ADS | 372303206 | $117.1M | 3,816,851 | 3.3% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $107.3M | 2,673,555 | 3.1% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $106.2M | 2,550,774 | 3.0% |
| Spdr Series Trust(XBI)Put | S&P BIOTECH | 78464A870 | $100.2M | 1,000,000 | 2.8% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $100.1M | 6,170,131 | 2.8% |
| Cidara Therapeutics Inc(CDTX) | COM NEW | 171757206 | $92.0M | 961,164 | 2.6% |
| Urogen Pharma LTD(URGN) | COM | M96088105 | $84.1M | 4,216,084 | 2.4% |
| Scholar Rock Hldg Corp(SRRK) | COM | 80706P103 | $74.8M | 2,009,745 | 2.1% |
| Janux Therapeutics Inc(JANX) | COM | 47103J105 | $71.4M | 2,920,258 | 2.0% |
| Olema Pharmaceuticals Inc(OLMA) | COM | 68062P106 | $66.5M | 6,794,172 | 1.9% |
| Apogee Therapeutics Inc(APGE) | COM | 03770N101 | $60.5M | 1,521,757 | 1.7% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $56.3M | 2,609,353 | 1.6% |
| Alkermes PLC(ALKS) | SHS | G01767105 | $51.6M | 1,719,334 | 1.5% |
| Lenz Therapeutics Inc(LENZ) | COM | 52635N103 | $50.0M | 1,073,461 | 1.4% |
| Pharvaris N V(PHVS) | COM | N69605108 | $45.8M | 1,835,494 | 1.3% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $45.3M | 3,156,398 | 1.3% |
| Ocular Therapeutix Inc(OCUL) | COM | 67576A100 | $40.9M | 3,497,307 | 1.2% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $35.5M | 684,277 | 1.0% |
| Erasca Inc(ERAS) | COM | 29479A108 | $29.6M | 13,560,017 | 0.8% |
| Eyepoint Pharmaceuticals Inc(EYPT) | COM NEW | 30233G209 | $28.6M | 2,005,365 | 0.8% |
| Merus N VCall | COM | N5749R100 | $28.2M | 300,000 | 0.8% |
| Tango Therapeutics Inc(TNGX) | COM | 87583X109 | $25.9M | 3,086,184 | 0.7% |
| Amylyx Pharmaceuticals Inc(AMLX) | COM | 03237H101 | $25.8M | 1,900,000 | 0.7% |
| Spyre Therapeutics Inc(SYRE) | COM NEW | 00773J202 | $24.6M | 1,467,266 | 0.7% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $24.0M | 1,898,950 | 0.7% |
| Bridgebio Oncology Therapeut(BBOT) | COM NEW | 107924102 | $21.6M | 1,866,141 | 0.6% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $16.4M | 247,716 | 0.5% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $10.4M | 372,869 | 0.3% |
| Agios Pharmaceuticals Inc(AGIO)Call | COM | 00847X104 | $8.0M | 200,000 | 0.2% |